在患有C型肝炎的患者中评估血液学,生物化学和凝血测试
Ieva Janulaityte1, Gintare Petkute2, Asta Maciuliene3
1Department of Laboratory Medicine, Faculty of Medicine, Academy of Medicine, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.
Medicina (Kaunas, Lithuania)
|November 27, 2025
概括
根据性别和病毒载量,C型肝炎病毒 (HCV) 感染对例行实验室检测的影响不同. 非侵入性标记提供了对炎症和营养的洞察力,有助于临床评估.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 临床化学 临床化学
背景情况:
- 肝炎C病毒 (HCV) 是慢性肝病的全球主要原因之一.
- 直接作用抗病毒药物提供高治愈率,但病毒载量和影响实验室标记的性别等因素需要澄清.
研究的目的:
- 研究HCV患者的血液学,生物化学和凝血概况.
- 分析根据性别和病毒水平分层的衍生型非侵入性指数.
主要方法:
- 对367名HCV患者 (223名男性,144名女性) 的回顾性研究.
- 患者被分为高/低病毒血症组 (值:800,000 IU/mL).
- 常规测试和计算指数的分析 (例如,FIB-4,APRI,NLR,SII).
主要成果:
- 在红细胞指数,凝血和淋巴细胞计数中观察到的性别和病毒特异性差异.
- 在低病毒血量男性中增加FIB-4/APRI;在高病毒血量女性中增加SII/PLR.
- 大多数指数在未检测到的HCVRNA治疗后显著改善.
结论:
- 感染HCV改变了基于性别和病毒性质的实验室概况.
- 非侵入性指数反映了炎症和营养状况,对临床评估有价值.
- 这些指数可以帮助产生假设和确定患者优先级.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
170
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
170
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
204
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
204


